Roivant Sciences Ownership | Who Owns Roivant Sciences?
Roivant Sciences Ownership Summary
Roivant Sciences is owned by 62.00% institutional investors, 27.64% insiders, and 10.36% retail investors. Qvt financial lp is the largest institutional shareholder, holding 8.95% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.30% of its assets in Roivant Sciences shares.
ROIV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Roivant Sciences | 62.00% | 27.64% | 10.36% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Qvt financial lp | 65.79M | 8.95% | $778.34M |
Sb investment advisers (uk) | 71.36M | 8.89% | $754.29M |
Fmr | 49.30M | 6.70% | $583.24M |
Viking global investors lp | 47.81M | 6.50% | $565.59M |
Vanguard group | 44.09M | 5.99% | $521.55M |
Blackrock funding, inc. /de | 42.16M | 5.73% | $498.72M |
Blackrock | 35.37M | 4.41% | $373.86M |
Morgan stanley | 29.33M | 3.65% | $310.02M |
Rubric capital management lp | 20.00M | 2.72% | $236.60M |
State street | 18.44M | 2.30% | $194.94M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Qvt financial lp | 65.79M | 69.37% | $778.34M |
Patient square capital lp | 12.23M | 59.99% | $129.25M |
Atalaya capital management lp | 1.71M | 40.31% | $18.13M |
Anchorage capital group | 4.83M | 20.12% | $57.17M |
Whitefort capital management, lp | 2.39M | 13.54% | $28.29M |
Two seas capital lp | 10.17M | 10.39% | $120.29M |
Tyro capital management | 1.74M | 8.36% | $18.44M |
Adar1 capital management | 3.51M | 8.30% | $41.51M |
Stempoint capital lp | 2.71M | 8.01% | $32.09M |
Sb investment advisers (uk) | 71.36M | 6.97% | $754.29M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ubs group | 5.29M | 0.01% | 4.78M |
Norges bank | 4.43M | 0.01% | 4.43M |
Invesco | 9.52M | 0.02% | 3.16M |
Vanguard group | 44.09M | 0.01% | 2.40M |
Toms capital investment management lp | 5.88M | 2.54% | 1.87M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 29.33M | 0.02% | -6.31M |
Viking global investors lp | 47.81M | 1.83% | -6.29M |
Avoro capital advisors | - | - | -4.65M |
Goldman sachs group | 2.11M | 0.00% | -3.28M |
Bvf inc/il | - | - | -2.74M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 4.43M | 0.01% | 4.43M | $52.44M |
Vestal point capital, lp | 1.25M | 0.88% | 1.25M | $14.79M |
Pearl river capital | 490.44K | 0.82% | 490.44K | $5.18M |
Bnp paribas arbitrage, snc | 468.01K | 0.00% | 468.01K | $5.54M |
Zimmer partners, lp | 252.90K | 0.05% | 252.90K | $2.99M |
Sold Out
Holder | Change |
---|---|
Mv capital management | -13.00 |
Mather group, llc. | -13.00 |
Riverview trust | -45.00 |
New millennium group | -54.00 |
Natixis | -68.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 293 | -4.87% | 455,984,070 | -19.26% | 61 | 1.05% | 142 | -20.22% | 95 | 35.71% |
Sep 30, 2024 | 306 | 0.66% | 564,022,060 | 3.35% | 76 | 1.39% | 177 | 4.12% | 69 | -14.81% |
Jun 30, 2024 | 303 | 14.34% | 545,755,248 | 3.61% | 67 | 1.57% | 169 | 6.29% | 81 | 24.62% |
Mar 31, 2024 | 265 | 10.88% | 526,729,372 | -2.70% | 65 | 1.60% | 159 | 8.90% | 65 | 22.64% |
Dec 31, 2023 | 239 | 10.65% | 541,335,285 | -0.37% | 64 | 1.25% | 146 | 3.55% | 53 | 10.42% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 23.56M | 3.30% | 519.87K |
Fidelity Growth Compy Commingled Pl O | 21.15M | 2.86% | 439.20K |
Fidelity Growth Company Fund | 16.64M | 2.33% | 355.10K |
Vanguard US Total Market Shares ETF | 14.26M | 2.00% | 14.26M |
iShares Core S&P Mid-Cap ETF | 13.73M | 1.92% | 4.48K |
Vanguard Total Stock Mkt Idx Inv | 13.63M | 1.91% | -1.21M |
Vanguard Small Cap Index | 10.69M | 1.50% | -1.39M |
Invesco S&P MidCap Quality ETF | 6.96M | 0.98% | -9.49K |
Vanguard Institutional Extnd Mkt Idx Tr | 6.51M | 0.91% | 3.83K |
SPDR® S&P Biotech ETF | 6.07M | 0.85% | -65.07K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 21, 2025 | Venker Eric | President & COO | Sell | $1.02M |
Mar 20, 2025 | Venker Eric | President & COO | Sell | $3.49M |
Mar 24, 2025 | Venker Eric | President & COO | Sell | $4.70M |
Feb 20, 2025 | Venker Eric | President & COO | Sell | $1.06M |
Feb 13, 2025 | Kumar Rakhi | Chief Accounting Officer | Sell | $2.37M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 1 |
2025 Q1 | - | 7 |
2024 Q4 | - | 8 |
2024 Q3 | - | 12 |
2024 Q2 | - | - |
ROIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools